Clinical studies recruiting near Clermont

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Evaluation of the Efficacy of an inTerdialytic "Ethanol 40% v/v - enoxapaRin 1000 U/mL" Lock solutioN to Prevent Tunnell
Phase 3 · CHU Clermont-Ferrand · University Hospital, Clermont-Ferrand · NCT03083184 A Platform Trial Evaluating New Drugs or Combination in R/R Peripheral T-cell Lymphomas
Phase 1/Phase 2 · CHU Estaing - Service Thérapie Cellulaire et Hématologie Cli · The Lymphoma Academic Research Organisation · NCT07018752 Observational Study Protocol: LIVER-R
Phase N/A · Research Site · AstraZeneca · NCT06252753 Glucocorticoids Versus Placebo for the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis
Phase 3 · CHU Clermont-Ferrand · Fondation Hôpital Saint-Joseph · NCT05674994 A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis
Phase 2 · Novum Research- Site Number : 8400018 · Sanofi · NCT06867094 Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
Phase 3 · Centre Jean Perrin - CLCC · Daiichi Sankyo · NCT07022483 A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line
Phase 3 · Clermont Oncology Center ( Site 0046) · Merck Sharp & Dohme LLC · NCT06136559 Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease
Phase 2/Phase 3 · Centre Jean Perrin - Centre Régional de Lutte contre le Canc · Bristol-Myers Squibb · NCT07106762 Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · Centre Jean Perrin - Centre Régional de Lutte contre le Canc · Merck Sharp & Dohme LLC · NCT06393374 Resting-state Imaging and OSteoporosiS
NA · CHU de Clermont-Ferrand · University Hospital, Clermont-Ferrand · NCT07030205 A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
Phase 3 · Local Institution - 0171 · Bristol-Myers Squibb · NCT06929273 CARPEUS : Effect of Carvedilol on the Portosystemic Gradient as Measured by Endoscopic Ultrasound
NA · Lise Laclautre · University Hospital, Clermont-Ferrand · NCT06861075 A Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerabili
Phase 1/Phase 2 · Centre Jean Perrin · Lumara Bio Oncologics GmbH · NCT05706129 Von Willebrand Factor Point-of-care Testing to Improve Minimally Invasive TAVI Outcomes
NA · Hopital Estaing - Chu63 - Clermont Ferrand · University Hospital, Lille · NCT03728049 Blockade of the Renin-angiotensin-aldosterone System in Patients With ARVD
Phase 2 · Hôpital Gabriel Montpied · Hospices Civils de Lyon · NCT03593317 Prevalence of Hyperemesis Gravidarum
Phase N/A · Reseau de Santé en Périnatalité d'Auvergne · University Hospital, Clermont-Ferrand · NCT06415084 Helping Osteoarthritis Patients to Walk With NSAID
Phase 4 · CHU Clemront-Ferrand · University Hospital, Clermont-Ferrand · NCT05761015 Non-Invasive Ventilation Versus High-flow Nasal Oxygen in Intensive Care Units
NA · Clermont-Ferrand University Hospital · Poitiers University Hospital · NCT05686850 Faecal Microbiota Transplantation After Allogeneic Stem Cell Transplantation
Phase 2 · Plateforme d'Investigation Clinique / Centre d'Investigation · University Hospital, Clermont-Ferrand · NCT04935684 Evaluation of EXL01, a New Live Biotherapeutic Product to Prevent Recurrence of Clostridioides Difficile Infection in Hi
Phase 1/Phase 2 · Service d'hépato-gastroentérologie - CHU Estaing · Hospices Civils de Lyon · NCT06306014 TTFields General Routine Clinical Care in ndGBM Patients: a French Prospective Non-Interventional Study (TIGER France)
Phase N/A · Centre Lutte Contre Le Cancer Jean Perrin · NovoCure Ltd. · NCT06924099 Study of the Impact of Mother-of-pearl Nutritional Supplementation on the Prevention of Post-menopausal Osteoporosis
NA · Hôpital Gabriel Montpied · Centre Hospitalier Universitaire de Saint Etienne · NCT05571514 The ECOSTRESS Study: Influence of the Objective Structured Clinical Examination on Stress Among Medical Student
Phase N/A · Medical School of Clermont-Ferrand · University Hospital, Clermont-Ferrand · NCT06138457 Transplantation After Complete Response In Patients With T-cell Lymphoma
NA · Chu Estaing · Hospices Civils de Lyon · NCT05444712 Orofacial Functions and Masticatory Function in Children With Different Types of Deterioration in Oral Health
NA · CHU clermont-ferrand · University Hospital, Clermont-Ferrand · NCT05821140 Mosunetuzumab-Lenalidomide Versus Investigator Choices in Patients With Relapsed or Refractory Marginal Zone Lymphoma
Phase 3 · Chu Estaing · The Lymphoma Academic Research Organisation · NCT06006117 DECIdE, Shared DECIsion in hEalth : the Real-life Impact Study
NA · CHU Clermont-ferrand · University Hospital, Clermont-Ferrand · NCT06052917 Impact on Quality of Life of Osteopathic Visceral Mobilizations After Endometriosis Surgery
NA · CHU de Clermont-Ferrand · University Hospital, Clermont-Ferrand · NCT06553989 cDNA and Residual Disease After Chemoradiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinomas
NA · Centre Jean PERRIN · Centre Jean Perrin · NCT07178847 A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine
Phase 3 · CHU Clermont Ferrand, Merz Investigational Site #0330026 · Merz Therapeutics GmbH · NCT07018700

Look up another city

Look up another condition